Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 533 of 5804
-
Prepping the body before heart surgery: could exercise shorten hospital stays?
Disease control CompletedThe objective of this clinical trial is to develop a novel rehabilitation model that, through the PRECICA program, will help to reduce perioperative and postoperative complications in the care process prior to planned cardiac surgery. This will be achieved by reducing the total p…
Phase: NA • Sponsor: Hospital Universitario 12 de Octubre • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Vending machines dispense lifesaving overdose reversal drug
Disease control OngoingVending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxo…
Phase: PHASE4 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New decision tool aims to catch childhood TB earlier in africa
Disease control Recruiting nowThe Decide-TB project aims to generate evidence for the implementation of a comprehensive Treatment Decision Algorithms (TDA) based approach for TB in children living in high TB burden and resource-limited countries, at District Hospital (DH) and Primary Health Centre (PHC) level…
Phase: NA • Sponsor: Chishala Chabala • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug oxacom® shows promise for treating rare lung condition
Disease control OngoingA multicenter, randomized, double-blind, placebo-controlled, phase II-III clinical trial to evaluate the efficacy and safety of the study drug in adult patients with pulmonary arterial hypertension (PAH). The trial will evaluate the efficacy and safety of both single and multi-d…
Phase: PHASE2, PHASE3 • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a fatty diet fight ALS?
Disease control Recruiting nowThis study aims at evaluating efficacy and tolerability of an ultra-high-caloric, fatty diet (UFD) compared to placebo in patients with amyotrophic lateral sclerosis (ALS).
Phase: NA • Sponsor: University of Ulm • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Boiled cashews could be key to taming cashew allergies in kids
Disease control Recruiting nowAs the global prevalence of food allergy steadily increases, tree nut (TN) becomes one of the main triggers of food-allergic reactions and food anaphylaxis. Since there is no effective cure, TN-allergic patients and their families must continue to live with this chronic, disablin…
Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a second drug boost stroke recovery?
Disease control Recruiting nowMulticentre, prospective, Multi-arm Multi-stage (MAMS) seamless phase 2b/3 interventional randomized placebo-controlled double-blinded parallel-assignment (2 arms with 1:1 randomization) efficacy and safety trial to test intra-arterial tenecteplase at the completion of thrombecto…
Phase: PHASE2, PHASE3 • Sponsor: University of Melbourne • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a wakefulness drug tame MS fatigue?
Symptom relief Recruiting nowFatigue is a prevalent and disabling symptom in Multiple Sclerosis (MS), affecting up to 90% of patients. Current treatments, including off-label prescriptions of wake-promoting agents, have shown limited effectiveness. Previous research indicates that these agents may be benefic…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Blood test could reveal hidden cancer spread in colorectal patients
Diagnosis Recruiting nowColorectal cancer is the third most common malignancy worldwide, and prognosis largely depends on how effectively metastatic disease is managed. The liver is the most frequent and prognostically important site of metastasis, and patients responding well to chemotherapy may become…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New hope for hodgkin lymphoma patients who Can't get transplants
Disease control Recruiting nowThe prognosis for patients with relapsed/refractory classical Hodgkin lymphoma (cHL) who refuse or are ineligible for transplant is poor. This open label, randomized, phase 2 study aims to evaluate the efficacy of Chidamide+Decitabine plus Anti-PD-1 Antibody and Brentuximab Vedot…
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for bleeding stroke: can clevidipine save brains?
Disease control Recruiting nowThe aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.
Sponsor: Zeenat Qureshi Stroke Institute • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Cannabis oil trial aims to tame seizures in rare genetic disorder
Disease control Recruiting now1\. To assess treatment efficacy with YCJ-01 by changes in the number of epileptic seizures in patients with refractory epilepsy secondary to Tuberous Sclerosis Complex. 2. To assess the safety of the treatment with YCJ-01 in patients with refractory epilepsy secondary to Tuberou…
Phase: PHASE3 • Sponsor: Oils4Cure • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Peer power: opioid users train friends and family to save lives
Prevention Recruiting nowThe purpose of this study is to test a social intervention focused on overdose prevention and care. In the investigators prior work, the investigators have shown that people who use opioids (PWUO) can be effective peer educators (PEs).
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
VR therapy shows promise for autism social skills
Symptom relief CompletedThe goal of this randomized clinical trial is to compare and learn about Virtual Reality (VR) in children with autism/Autistic children. The main question it aims to answer is: • Does the Floreo VR clinical product show clinical improvement in autism symptoms? Participants wil…
Phase: NA • Sponsor: Floreo, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New radiation technique may help more liver cancer patients get transplants
Disease control Recruiting nowThe aim of this trial is to carry out the first prospective multicentric study which evaluates the efficacy and the safety of SBRT in HCC patients enlisted for LT and not suitable for other bridging interventional treatments (RF or TACE). The incidence of hepatocellular carcinom…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New shot aims to cut bleeding in hemophilia patients
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, immunogenicity , PK, and PD of a single dose of SR604 in participants with Hemophilia A or Hemophilia B, with or without inhibitors (Part A)and to evaluate the safety, PK, PD, and efficacy of multiple doses of SR6…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai RAAS Blood Products Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New 4-Drug cocktail aims to control Hard-to-Treat myeloma
Disease control Recruiting nowThe main goal of this phase II study is to evaluate the overall response rate of isatuximab, belantamab mafodotin, pomalidomide, and dexamethasone in relapsed and refractory multiple myeloma. The study drugs provided for research purposes are isatuximab and belantamab mafodotin.
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug cocktail aims to wipe out aggressive prostate cancer before surgery
Disease control Recruiting nowThe purpose of this study is to learn about how an investigational drug intervention completed before doing prostate surgery (specifically, radical prostatectomy with lymph node dissection) may help in treatment of high risk localized prostate cancers that are most resistant to s…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for lung scarring after transplant: belumosudil trial launches
Disease control Recruiting nowThe goal of this research study is to test the efficacy of a novel immunosuppressive agent, belumosudil, in allogeneic hematopoietic stem cell transplant (HSCT) recipients who have been newly diagnosed or have developing (early stage) bronchiolitis obliterans syndrome (BOS). The…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New liposomal drug combo aims to boost lymphoma remission
Disease control Recruiting nowThis is a prospective clinical study to evaluate the safety and efficacy of R-CMOP in patients with newly diagnosed diffuse large B-cell lymphoma
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC